Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?

scientific article published on August 2007

Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1098/RSIF.2007.0216
P932PMC publication ID2373392
P698PubMed publication ID17287181
P5875ResearchGate publication ID6517969

P50authorAzra GhaniQ60550218
Robert G. WillQ118106031
P2093author name stringPaul Clarke
P2860cites workThe same prion strain causes vCJD and BSEQ57092996
Long-term survival after blood transfusion: a population based study in the North of EnglandQ80260178
Where does blood go? Prospective observational study of red cell transfusion in north EnglandQ34148352
On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populationsQ34155650
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patientQ34339769
Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapiesQ34489473
Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence studyQ34622879
Subclinical prion infection in humans and animalsQ35548998
Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty.Q36302930
Pathogenesis and prevalence of variant Creutzfeldt-Jakob diseaseQ36346109
Clinical implications of emerging pathogens in haemophilia: the variant Creutzfeldt-Jakob disease experienceQ36381542
Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review studyQ36588347
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humansQ36782262
Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instrumentsQ39018369
BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion proteinQ39686522
Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibilityQ40306174
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrierQ40624584
Predicting susceptibility and incubation time of human-to-human transmission of vCJD.Q43220422
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agentQ44592404
Pathogenesis of mouse scrapie: Effect of route of inoculation on infectivity titres and dose-response curvesQ45177416
Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.Q47278870
Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.Q50789460
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.Q51037857
Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain.Q52226096
Predicted vCJD mortality in Great BritainQ56830897
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectepidemicQ44512
Creutzfeldt-Jakob diseaseQ49989
P304page(s)675-684
P577publication date2007-08-01
P1433published inJournal of the Royal Society InterfaceQ2492390
P1476titleIs there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?
P478volume4

Reverse relations

cites work (P2860)
Q35875915Could immunomodulation be used to prevent prion diseases?
Q39018369Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments
Q26741073Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use
Q34565644Immunomodulation for prion and prion-related diseases
Q55005212Initial Results of a Prospective Study and Identification of New Strategies to Increase Traceability of Plasma-derived Medicines.
Q90163542PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease
Q36732837Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease
Q34086359Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated Septembe
Q50475230Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States.
Q33784392Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK.

Search more.